TADA2A-C17ORF78 Fusion FISH Probe
The TADA2A-C17ORF78 Fusion FISH Probe is used to confirm a fusion of the TADA2A and C17ORF78 genes. The fusion of the TADA2A and C17ORF78 genes has been associated with Uveal Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TADA2A-C17ORF78-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-C17ORF78-20-AQAQ | 20 (40 μL) | 200 μL |
|
TADA2A Gene Summary
Many DNA-binding transcriptional activator proteins enhance the initiation rate of RNA polymerase II-mediated gene transcription by interacting functionally with the general transcription machinery bound at the basal promoter. Adaptor proteins are usually required for this activation, possibly to acetylate and destabilize nucleosomes, thereby relieving chromatin constraints at the promoter. The protein encoded by this gene is a transcriptional activator adaptor and has been found to be part of the PCAF histone acetylase complex. Several alternatively spliced transcript variants encoding different isoforms of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2009]
Gene Name: Transcriptional Adaptor 2A
Chromosome: CHR17: 35766976 -35837226
Locus: 17q12
C17orf78 Gene Summary
The Chromosome 17 Open Reading Frame 78 (C17orf78) gene is located on chr17 :35732984-35749662 at 17q12.
Gene Name: Chromosome 17 Open Reading Frame 78
Chromosome: CHR17: 35732984 -35749662
Locus: 17q12
Gene Diseases
The TADA2A C17ORF78 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uveal Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|